Related Experiment Video
Updated: Jun 4, 2026

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting
Published on: May 1, 2015
Gorham's disease and diffuse lymphangiomatosis in children and adolescents
Rajkumar Venkatramani1, Nina S Ma, Pisit Pitukcheewanont
1Division of Hematology/Oncology, Children's Hospital Los Angeles, Los Angeles, California 90027, USA.
Insights
Gorham's disease, a rare vascular disorder, can affect children. Treatment with interferon alpha-2b and bisphosphonate therapy showed disease stabilization and improvement in eight pediatric patients.
Area of Science:
- Vascular Biology
- Pediatric Oncology
- Rare Diseases
Background:
- Gorham's disease is a rare, idiopathic disorder characterized by vascular proliferation and bone resorption.
- It is often underdiagnosed or misdiagnosed due to variable clinical presentations.
- No established treatment guidelines exist for Gorham's disease.
Purpose of the Study:
- To report on the clinical characteristics and treatment outcomes of pediatric patients with Gorham's disease.
- To evaluate the efficacy of interferon alpha-2b and bisphosphonate therapy in managing this condition.
- To highlight the association of Gorham's disease with soft tissue lymphangioma and splenic involvement in children.
Main Methods:
- Retrospective review of eight pediatric patients diagnosed with Gorham's disease over a ten-year period.
- Analysis of clinical data, including presence of lymphangioma and splenic involvement.
- Assessment of treatment response to interferon alpha-2b and bisphosphonate therapy.
Main Results:
- Seven out of eight children presented with soft tissue lymphangioma.
- Six out of eight children had splenic involvement.
- Disease stabilization and improvement were observed in patients treated with interferon alpha-2b and bisphosphonate therapy.
Conclusions:
- Interferon alpha-2b and bisphosphonate therapy may be effective in managing Gorham's disease in children.
- Early recognition and multidisciplinary management are crucial for improving outcomes.
- Further research is warranted to establish standardized treatment protocols for Gorham's disease.
Abstract:
Gorham's disease is a rare disorder of unknown etiology and variable clinical presentation that is characterized by proliferation of thin-walled vascular channels resulting in destruction and resorption of osseous matrix. The condition is frequently under recognized or misdiagnosed. There is no standard treatment defined for this disease. Here we report on eight children diagnosed with Gorham's disease at our institution over a ten-year period. Soft tissue lymphangioma was present in seven and six children had splenic involvement. Disease stabilization and improvement was observed on treatment with interferon alpha-2b and bisphosphonate therapy.
Related Concept Videos
Secondary Lymphoid Organs
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
Goiter
Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Abnormal Proliferation
Graves Disease II: Pathophysiology
Graves' Disease I: Introduction